<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Barmada SJ</submitter><funding>NIMH NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>Motor Neurone Disease Association</funding><pagination>677-85</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4106236</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(8)</volume><pubmed_abstract>Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) have distinct clinical features but a common pathology--cytoplasmic inclusions rich in transactive response element DNA-binding protein of 43 kDa (TDP43). Rare TDP43 mutations cause ALS or FTD, but abnormal TDP43 levels and localization may cause disease even if TDP43 lacks a mutation. Here we show that individual neurons vary in their ability to clear TDP43 and are exquisitely sensitive to TDP43 levels. To measure TDP43 clearance, we developed and validated a single-cell optical method that overcomes the confounding effects of aggregation and toxicity and discovered that pathogenic mutations shorten TDP43 half-life. New compounds that stimulate autophagy improved TDP43 clearance and localization and enhanced survival in</pubmed_abstract><journal>Nature chemical biology</journal><pubmed_title>Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models.</pubmed_title><pmcid>PMC4106236</pmcid><funding_grant_id>U24 NS078370</funding_grant_id><funding_grant_id>R43 NS081844</funding_grant_id><funding_grant_id>CHANDRAN/MAR10/982-797</funding_grant_id><funding_grant_id>K08 NS072233</funding_grant_id><funding_grant_id>R01 NS083390</funding_grant_id><funding_grant_id>U01 MH1050135</funding_grant_id><funding_grant_id>3R01 NS039074</funding_grant_id><funding_grant_id>U01 MH105035</funding_grant_id><funding_grant_id>R01 NS039074</funding_grant_id><pubmed_authors>Bilican B</pubmed_authors><pubmed_authors>Peisach D</pubmed_authors><pubmed_authors>Shaw C</pubmed_authors><pubmed_authors>Tsvetkov A</pubmed_authors><pubmed_authors>Barmada SJ</pubmed_authors><pubmed_authors>Ando DM</pubmed_authors><pubmed_authors>Serio A</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Finkbeiner S</pubmed_authors><pubmed_authors>Arjun A</pubmed_authors><pubmed_authors>Pleiss M</pubmed_authors><pubmed_authors>Daub A</pubmed_authors><pubmed_authors>Chandran S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models.</name><description>Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) have distinct clinical features but a common pathology--cytoplasmic inclusions rich in transactive response element DNA-binding protein of 43 kDa (TDP43). Rare TDP43 mutations cause ALS or FTD, but abnormal TDP43 levels and localization may cause disease even if TDP43 lacks a mutation. Here we show that individual neurons vary in their ability to clear TDP43 and are exquisitely sensitive to TDP43 levels. To measure TDP43 clearance, we developed and validated a single-cell optical method that overcomes the confounding effects of aggregation and toxicity and discovered that pathogenic mutations shorten TDP43 half-life. New compounds that stimulate autophagy improved TDP43 clearance and localization and enhanced survival in</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014 Aug</publication><modification>2025-04-19T04:16:11.103Z</modification><creation>2019-03-27T01:32:31Z</creation></dates><accession>S-EPMC4106236</accession><cross_references><pubmed>24974230</pubmed><doi>10.1038/nchembio.1563</doi></cross_references></HashMap>